Sustaining Blood Lymphocyte Count during Preoperative Chemoradiotherapy as a Predictive Marker for Pathologic Complete Response in Locally Advanced Rectal Cancer
2
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Purpose The objective of this study was to explore the relationship between the circulating lympho- cyte level during preoperative chemoradiotherapy (CRT) and pathologic complete response (pCR) in locally advanced rectal cancer. Materials and Methods From May 2010 to May 2013, 52 patients treated with preoperative CRT followed by surgery, were analysed. Patients received conventional fractionated radiotherapy (50-54 Gy) with fluorouracil-based chemotherapy. Surgical resection was performed at 4 to 8 weeks after the completion of preoperative CRT. Absolute blood lymphocyte counts and their rel- ative percentage in total white blood cell counts were obtained from complete blood count tests performed prior to and after 4, 8, and 12 weeks of CRT. We analysed the association between achieving pCR and change in blood lymphocyte level during CRT, as well as clinical parameters. Results Among 52 patients, 14 (26.9%) had evidence of pCR. Sustaining the blood lymphocyte count during CRT (lymphocyte count at 4 weeks/baseline lymphocyte count > 0.35; odds ratio, 8.33; p=0.02) and initial carcinoembryonic antigen < 4.4 ng/mL (odds ratio, 6.71; p=0.03) were significantly associated with pCR in multivariate analyses. Conclusion Sustaining blood lymphocyte count during preoperative CRT was predictive for pCR in rectal cancer. Further studies are warranted to investigate the association between pathologic responses and circulating lymphocyte count with its subpopulation during preoperative CRT.
Abstract
Purpose The objective of this study was to explore the relationship between the circulating lympho- cyte level during preoperative chemoradiotherapy (CRT) and pathologic complete response (pCR) in locally advanced rectal cancer. Materials and Methods From May 2010 to May 2013, 52 patients treated with preoperative CRT followed by surgery, were analysed. Patients received conventional fractionated radiotherapy (50-54 Gy) with fluorouracil-based chemotherapy. Surgical resection was performed at 4 to 8 weeks after the completion of preoperative CRT. Absolute blood lymphocyte counts and their rel- ative percentage in total white blood cell counts were obtained from complete blood count tests performed prior to and after 4, 8, and 12 weeks of CRT. We analysed the association between achieving pCR and change in blood lymphocyte level during CRT, as well as clinical parameters. Results Among 52 patients, 14 (26.9%) had evidence of pCR. Sustaining the blood lymphocyte count during CRT (lymphocyte count at 4 weeks/baseline lymphocyte count > 0.35; odds ratio, 8.33; p=0.02) and initial carcinoembryonic antigen < 4.4 ng/mL (odds ratio, 6.71; p=0.03) were significantly associated with pCR in multivariate analyses. Conclusion Sustaining blood lymphocyte count during preoperative CRT was predictive for pCR in rectal cancer. Further studies are warranted to investigate the association between pathologic responses and circulating lymphocyte count with its subpopulation during preoperative CRT.
참고문헌 (23)
- Sauer R, "Preoperative versus postoperative chemoradiotherapy for rectal cancer", N Engl J Med, 351, pp.1731~1740 (2004)
- 공문규, "Preoperative Concurrent Chemoradiotherapy for Locally Advanced Rectal Cancer: Treatment Outcomes and Analysis of Prognostic Factors", Cancer Research and Treatment, 44(2), pp.104~112 (2012), 대한암학회[DOI]
- Martin ST, "Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer", Br J Surg, 99, pp.918~928 (2012)
- Maas M, "Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer : a pooled analysis of individual patient data", Lancet Oncol, 11, pp.835~844 (2010)
- Yeo SG, "Pathologic complete response of primary tumor following preoperative chemoradiotherapy for locally advanced rectal cancer : long-term outcomes and prognostic significance of pathologic nodal status(KROG 09-01)", Ann Surg, 252, pp.998~1004 (2010)
- Yoon SM, "Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer", Int J Radiat Oncol Biol Phys, 69, pp.1167~1172 (2007)
- Restivo A, "Elevated CEA levels and low distance of the tumor from the anal verge are predictors of incomplete response to chemoradiation in patients with rectal cancer", Ann Surg Oncol, 20, pp.864~871 (2013)
- Rodel C, "Apoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer", Int J Radiat Oncol Biol Phys, 52, pp.294~303 (2002)
- Kuremsky JG, "Biomarkers for response to neoadjuvant chemoradiation for rectal cancer", Int J Radiat Oncol Biol Phys, 74, pp.673~688 (2009)
- Chihwan Choi, "Clinical predictive factors of pathologic tumor response after preoperative chemoradiotherapy in rectal cancer", Radiation oncology journal, 30(3), pp.99~107 (2012), 대한방사선종양학회[DOI]
- Kitayama J, "Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer", Radiat Oncol, 5, pp.47~ (2010)
- Schmidt MA, "Circulating regulatory T cells of cancer patients receiving radiochemotherapy may be useful to individualize cancer treatment", Radiother Oncol, 104, pp.131~138 (2012)
- Campian JL, "Treatment-related lymphopenia in patients with stage III non-small-cell lung cancer", Cancer Invest, 31, pp.183~188 (2013)
- Wild AT, "The association between chemoradiation-related lymphopenia and clinical outcomes in patients with locally advanced pancreatic adenocarcinoma", Am J Clin Oncol (2013)[DOI]
- Denkert C, "Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer", J Clin Oncol, 28, pp.105~113 (2010)
- Naito Y, "CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer", Cancer Res, 58, pp.3491~3494 (1998)
- Ropponen KM, "Prognostic value of tumour-infiltrating lymphocytes(TILs)in colorectal cancer", J Pathol, 182, pp.318~324 (1997)
- Haustermans K, "The ESTRO Breur Lecture 2010 : toward a tailored patient approach in rectal cancer", Radiother Oncol, 100, pp.15~21 (2011)
- Lissoni P, "Effects of the conventional antitumor therapies surgery, chemotherapy, radiotherapy and immunotherapy on regulatory T lymphocytes in cancer patients", Anticancer Res, 29, pp.1847~1852 (2009)
- Schuler PJ, "Dendritic cell generation and CD4+ CD25high FOXP3+ regulatory t cells in human head and neck carcinoma during radio-chemotherapy", Eur J Med Res, 16, pp.57~62 (2011)
- Ray-Coquard I, "Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas", Cancer Res, 69, pp.5383~5391 (2009)
- Grossman SA, "Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide", Clin Cancer Res, 17, pp.5473~5480 (2011)
- Yovino S, "The etiology of treatment-related lymphopenia in patients with malignant gliomas : modeling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells", Cancer Invest, 31, pp.140~144 (2013)